Related Experiment Video
Updated: Jul 21, 2026
11:38
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
The 2021 Core Content of Medical Toxicology
Robert G Hendrickson1, Theodore C Bania2, Carl R Baum3
1Oregon Poison Center, Fellowship in Medical Toxicology, Department of Emergency Medicine, Oregon Health and Science University (OHSU), 3181 SW Sam Jackson Park Road, CSB 550, Portland, OR, 97239, USA.
Summary
The Medical Toxicology Subboard updated essential knowledge for medical toxicology practice in March 2021. This core content guides certification exams and fellowship training curricula.
Area of Science:
- Medical Toxicology
- Medical Education
- Professional Certification
Background:
- The practice of medical toxicology requires a defined body of essential knowledge.
- Standardization of knowledge is crucial for consistent training and assessment.
Purpose of the Study:
- To outline the essential knowledge areas for medical toxicology practice.
- To provide a framework for developing certification examinations.
- To serve as a template for medical toxicology fellowship curricula.
Main Methods:
- Review and approval of modifications to the Core Content of Medical Toxicology by the Medical Toxicology Subboard.
- Document outlining essential knowledge areas.
Main Results:
- The Medical Toxicology Subboard approved modifications to the Core Content in March 2021.
- The updated Core Content defines essential knowledge for medical toxicology practice.
Conclusions:
- The revised Core Content provides a foundational framework for medical toxicology.
- This framework supports the development of certification exams and fellowship training programs.
Related Concept Videos
01:26Drug Discovery: Overview
10.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.1K
01:19Pharmacovigilance
1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K
01:36Types of Toxins
2.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.7K
01:26Toxic Reactions: Overview
1.4K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.4K
01:17Antidotes
840
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
840
01:26Anticholinesterase Agents: Poisoning and Treatment
1.2K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.2K